Literature DB >> 31645794

The Benefits of Marine Omega-3s for the Prevention and Treatment of Cardiovascular Disease.

James J DiNicolantonio1, James H O'Keefe1.   

Abstract

There has been a raging debate whether marine omega-3s are effective for the prevention of cardiovascular disease. Our review paper discusses the landmark clinical studies testing the benefits of marine omega-3s. Moreover, for the first time, the REDUCE-IT study tested a high dose of marine omega-3s (4 grams of icosapent ethyl per day) on top of statin therapy in patients with established cardiovascular disease or with diabetes and additional risk factors with concomitant high triglyceride levels and noted a highly significant 25% reduction in the primary endpoint. Thus, in patients who are not in the early post myocardial infarction setting, high dose marine omega-3s (4 grams per day) may be required to provide cardiovascular benefit when given on top of optimized medical therapy. Copyright 2019 by the Missouri State Medical Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31645794      PMCID: PMC6797026     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  23 in total

1.  Medical studies in North Greenland 1948-1949. VI. Blood pressure. Hypertension and arteriosclerosis in relation to food and mode of living.

Authors:  M C EHRSTROM
Journal:  Acta Med Scand       Date:  1951

2.  Fish consumption and all-cause mortality: a meta-analysis of cohort studies.

Authors:  L-G Zhao; J-W Sun; Y Yang; X Ma; Y-Y Wang; Y-B Xiang
Journal:  Eur J Clin Nutr       Date:  2015-05-13       Impact factor: 4.016

3.  Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.

Authors:  JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; Christine M Albert; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

4.  Vegetarian dietary patterns and mortality in Adventist Health Study 2.

Authors:  Michael J Orlich; Pramil N Singh; Joan Sabaté; Karen Jaceldo-Siegl; Jing Fan; Synnove Knutsen; W Lawrence Beeson; Gary E Fraser
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

5.  The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  C von Schacky; P Angerer; W Kothny; K Theisen; H Mudra
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

Review 6.  Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].

Authors:  Manuela Casula; Davide Soranna; Alberico L Catapano; Giovanni Corrao
Journal:  Atheroscler Suppl       Date:  2013-08       Impact factor: 3.235

7.  Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

8.  Fish consumption and incidence of stroke: a meta-analysis of cohort studies.

Authors:  Ka He; Yiqing Song; Martha L Daviglus; Kiang Liu; Linda Van Horn; Alan R Dyer; Uri Goldbourt; Philip Greenland
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

9.  Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

Authors:  J Dyerberg; H O Bang; E Stoffersen; S Moncada; J R Vane
Journal:  Lancet       Date:  1978-07-15       Impact factor: 79.321

10.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Roberto Marchioli; Simona Barlera; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Gian Luigi Nicolosi; Maurizio Porcu; Gianni Tognoni
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.